Clinical Trials on Rehabilitation, Tenodesis, Stroke, Internet of Things in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
- Oblikue Consulting
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Eurotrials Brasil Consultores Cientificos Ltda
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Arsha Vidya Tirtha
- University of Applied Sciences Jena
- Rivierduinen, Centre for Personality disorders Jelgersma
- Paulo Sérgio Gomes Nogueira Borges
- Julian Taylor Green
- Sudimplant SAS - Groupe TBR
- Korea Otsuka International Asia Arab
- Foshan Sanshui District People's Hospital
- United States Department of Defense (DOD)
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Gunkang Pharmaceuticals, Inc
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Iyad Naeem Muhammad, PhD
- Plethora Solutions Ltd
- Lilly PharmaceuticalCompany
- S-Biotek Holding ApS
- View Full List
Medical Conditions
- Vibration; Exposure
- Chemotherapy-Induced Neutropenia
- Blepharospasm of Both Eyelids
- Serum Albumin Low
- Brain Tumor, Primary
- Testicular Teratoma
- Deformity Flexion
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Gray Platelet Syndrome
- Immunologically-induced Lung Disease
- Anemia Acute
- Puberty, Delayed
- Visual Attention Span Deficit
- Hypothermia Following Anesthesia, Sequela
- Thyroid and Parathyroid Surgery
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Advance Directive Completion
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Huntington Chorea
- Malaria,Falciparum
- View Full List
Drug Interventions
- Acalabrutinib in combination with VR
- Pegfilgrastim
- Bimatoprost 0.03% eye drops
- Cytisine
- MMV390048 120mg
- Pemetrexed
- Oxycodone
- F520
- Vosaroxin
- Mineralocorticoid receptor antagonist
- ABY-035 i.v.
- Furmonertinib 160 mg
- Standard medical therapy
- S-Adenosyl-Methionine
- Sorafenib
- Rovalpituzumab tesirine
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Celecoxib
- Ebselen
- Cyanoacrylate
- View Full List
CROs by country
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Finland
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Italy
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Peru
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Türkiye
- CRO list by country